- Home
- WEST vs PHAR Comparison
WEST vs PHAR Comparison
Compare WEST & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- PHAR
- Stock Information
- Founded
- WEST 2009
- PHAR 1988
- Country
- WEST United States
- PHAR Netherlands
- Employees
- WEST N/A
- PHAR N/A
- Industry
- WEST Beverages (Production/Distribution)
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- WEST Consumer Staples
- PHAR Health Care
- Exchange
- WEST Nasdaq
- PHAR Nasdaq
- Market Cap
- WEST 601.4M
- PHAR 627.5M
- IPO Year
- WEST N/A
- PHAR N/A
- Fundamental
- Price
- WEST $7.35
- PHAR $7.76
- Analyst Decision
- WEST Strong Buy
- PHAR Strong Buy
- Analyst Count
- WEST 5
- PHAR 2
- Target Price
- WEST $12.20
- PHAR $33.50
- AVG Volume (30 Days)
- WEST 66.8K
- PHAR 6.7K
- Earning Date
- WEST 11-07-2024
- PHAR 10-24-2024
- Dividend Yield
- WEST N/A
- PHAR N/A
- EPS Growth
- WEST N/A
- PHAR N/A
- EPS
- WEST N/A
- PHAR N/A
- Revenue
- WEST $836,715,000.00
- PHAR $285,745,000.00
- Revenue This Year
- WEST $5.15
- PHAR $20.89
- Revenue Next Year
- WEST $28.78
- PHAR $11.15
- P/E Ratio
- WEST N/A
- PHAR N/A
- Revenue Growth
- WEST N/A
- PHAR 30.64
- 52 Week Low
- WEST $5.28
- PHAR $6.65
- 52 Week High
- WEST $11.21
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- WEST 58.52
- PHAR 42.78
- Support Level
- WEST $6.34
- PHAR $7.70
- Resistance Level
- WEST $6.97
- PHAR $8.28
- Average True Range (ATR)
- WEST 0.40
- PHAR 0.40
- MACD
- WEST 0.01
- PHAR -0.07
- Stochastic Oscillator
- WEST 77.10
- PHAR 32.73
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.